posted
You might want to check out HCCF, looks like a very promising company!
HEE Corp Pilot Project Confirms Promise for Type II Diabetes
March 22, 2005 21:33:06 (ET)
HUTCHINSON, Kan., March 22, 2005 /PRNewswire-FirstCall via COMTEX/ -- HEE Corporation, Inc. (HCCF on OTC Pink Sheets), whose product is HPB-84, a nutraceutical developed in India, announced today information regarding their pilot project and their distribution. "HEE Corp continues to generate solid marketplace interest in its Type II Diabetes nutraceutical, HPB-84, and it has developed a base of enthusiastic and satisfied users," explains Herbert Becker. "Since joining HEE as the Interim-CEO and Chairman of the Board a few weeks ago, together with members of my staff, we have conducted a thorough review of the Company's business and its impact in order to determine how to accelerate marketplace penetration."
With this in mind, the company is on the verge of opening an e-commerce site to sell its product, worldwide. The company is also looking at other forms of distribution through established e-commerce sites as well as "bricks and mortar" outlets.
Regarding its pilot project
"As the pilot program initial findings begin to emerge," says HEE President Radley Brooks, "I think that there will be some confusing info going out with the current results and comparing them to Ron and Stan (two of the original users of HPB-84). One thing the public should know is that the product was administered in raw form to Ron and Stan while overseas. They had to hold raw, loose herbs in their cheek for 30 minutes and then swallow. The tablets are going to take longer than the raw form held in the cheek. With the pilot project at PRN the patients were given a titration schedule where they increased the dosing each day. This was done to give us an idea of an effective dose based on weight. I have no doubt the product will have the same effect, but it will take longer given the administration through the digestive system."
Of the nine individuals who have started the 12 week pilot project, 4 have now completed their mid-point (6 week) lab studies. The 12 week pilot project is projected to be completed by the end of May.
At this point in the project no conclusions can be drawn. These observations, however, have been made:
* All nine have tolerated the nutraceutical well.
* Several patients have needed to reduce their oral diabetic medications
or insulin.
SOURCE HEE Corporation, Inc.
Darci Brooks, Investor Relations of HEE Corporation, Inc., +1-620-663-3333, darci@hee-corp.com
Topic Closed
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
